NewsDialy
A trillion-dollar market cap, the point at which the combined market value of a company's shares tops $1 trillion, is a threshold many investors read as a ceiling.
Eli Lilly (NYSE: LLY) has just crossed it, trading at $1,123.98 with a market capitalization of $1.002 trillion. rate the stock a buy, with a 12-month price target of $1,220.42 and a stated confidence level of 90%.
The short version: shares are up 50.72% over the past year and down 8.61% over the past month, sitting below the 52-week high of $1,292.65.
What the revenue numbers show Mounjaro and Zepbound, Eli Lilly's diabetes and weight-loss drugs, have been the revenue engine. Second-quarter 2026 revenue reached $22.974 billion, up 47.67% year over year.
Keep reading